Article, News
Prescient Therapeutics at forefront of overcoming challenges, with game-changing CAR-T cell cancer therapies
CAR-T therapy is leading the race as the holy grail to cure cancer but like many medical therapies it is not without problems, which Prescient Therapeutics…
Article, News
The cancer-fighting tech disabling ‘force fields’ around tumours
SX-listed biotech Prescient Therapeutics has unveiled the second component of its CellPryme cell therapy enhancement platform on stage at the prestigious CAR-TCR Summit in Boston….
Article, News
Prescient Therapeutics debuts CellPryme-A at world’s largest CAR-TCR meeting in Boston
At the world’s largest CAR-TCR meeting, Prescient Therapeutics (ASX: PTX) has debuted CellPryme-A, which is a novel adjuvant designed to be administered to cancer patients in combination…
Article, News
Prescient unveils latest big hitter CellPryme-A at prestigious Boston CAR-TCR meeting
Prescient has unveiled the latest technology in its cancer-fighting portfolio CellPryme-A at the 7th annual CAR-TCR Summit in Boston, the world’s pre-eminent forum in the CAR…
Article, News
Biotechnology investing for the social good – making money and a difference
There are many foundations and charities which aim to tackle health conditions through funding medical research to develop better treatment options, improve patient outcomes and…
Article, News
Prescient Therapeutics unveils novel adjuvant for enhancing cellular immunotherapy: CellPryme-A
CellPryme-A is the latest in a portfolio of platform cell technologies that can not only create innovative programs for Prescient, but are also enabling technologies…
Article, News
Prescient (ASX:PTX) unveils exciting CellPryme-A data at world’s largest CAR-TCR meeting
Prescient Therapeutics (ASX: PTX) has presented exciting new data on CellPryme-A at the 7th Annual CAR-TCR Summit in Boston, MA. The summit is one of the…
News
Cancer therapy renaissance
The cancer drug market could be on the cusp of a timely renaissance as new therapies come to the forefront of treatment, with around 25,000…
News
Prescient Therapeutics to unveil CellPryme-A platform at CAR-TCR summit in Boston
Prescient Therapeutics Ltd (ASX:PTX) has been invited to present two sessions at the upcoming CAR-TCR Summit in Boston on September 19 to 22, during which the…